SITEMAP
- Κεντρική Σελίδα
-
Science
- Cutting-Edge Science
- Inspiration and Innovation
-
Cardiovascular
- Thrombosis
-
Dyslipidemia
-
Cutting Edge Science
-
2021
- NEJM Odyssey Outcomes
- The ROSETTE Study
- The EXPLORER Study
- ODYSSEY Outcomes
- Odyssey Outcomes - DM sub-analysis
- Odyssey Outcomes - Elderly Patients Results
- Odyssey Outcomes - CABG Results
- Odyssey Outcomes - PVD Results
- Odyssey Outcomes - Total Events Results
- Odyssey Outcomes - Mortality
- ESC/EAS 2019 International Guidelines
- The ACTE Study
- Odyssey Outcomes - Total Events Analysis
- Effect of Alirocumab on MACE in patients with CKD
- Odyssey Outcomes - CVOT Mortality Sub-analysis
- Odyssey Outcomes - PVD Sub-analysis
- Regulate LDL-C level for those undergoing coronary revascularization (Diabetic Patients)
- Real-life safety and efficacy of Alirocumab - ODYSSEY APPRISE study
- Optimal use of LLT after ACS
-
2022
- Pr. Nicholls, Head of Victorian Heart Hospital, Melbourne, Australia
- KOL video Prof. Kausik
- KOL video Prof. Kausik Chapter 3
- KOL Videos - Chapter 1 ACS Patients are at Very High Risk
- ACS Campaign Europath
- ACS Campaign Treat Early Guidance
- ACS Campaign Patient identification
- Κατευθυντήριες οδηγίες ESC/EAS 2019 για τη Διαχείριση της Δυσλιπιδαιμίας
- Innovation
- 2023
-
2021
-
Cutting Edge Science
- Atherothrombosis
- Cutting Edge Science
-
Diabetes
-
Cutting Edge Science
- 2021
-
Innovation
- T1DM Mini-Series: How to Avoid Hypoglycaemia in People with T1 Diabetes?
- T1DM Mini-Series: How Does Hypoglycaemia impact the life of people with T1 Diabetes?
- T1DM Mini-Series: Relevance of Edition JUNIOR trial results for the HCP and PTS life
- T1DM Mini-Series: Edition JUNIOR trial results
- T1DM Mini-Series: Severe hypoglycaemia compromises the achievement of glycaemic control
- T1DM Mini-Series: The main challenge for the kids and adolescents with T1
- 2022
- 2023
-
Cutting Edge Science
- Rare Blood Disorders
- Patient Support
-
Events
-
Cardiovascular
-
2021
- VTE Safety Zone: Assessing the VTE Risk in Hospital and Beyond
- Thrombosis Webinars: VTE risk & Thromboprophylaxis in primary care settings
- Thrombosis Webinars: Thromboprophylaxis for the medical ill patients in primary care settings
- Optimize the Secondary Prevention in ACS: from Guideline to Real Life
- 2022
-
2023
- Μιλάμε για την LDL-C Podcast #1 Μεταφράζοντας τα δεδομένα των κλινικών δοκιμών σε ενέργειες κλινικής πρακτικής: Έχουμε φτάσει εκεί που θέλουμε
- Μιλάμε για την LDL-C Podcast #2 Οικογενής Υπερχοληστερολαιμία
- Μιλάμε για την LDL-C Podcast #3 Δυσανεξία στις στατίνες
- Μιλάμε για την LDL-C Podcast #4 Ποιες είναι οι αποζημιούμενες ενδείξεις των PCSK9i
- Webinar video "Μιλάμε για την LDL-c" session 1
- Webinar video "Μιλάμε για την LDL-c" session 2
-
2021
- Diabetes
- Rare Blood Disorders
-
Cardiovascular
- Search